Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

46 results about "Protein species" patented technology

Proteins are species -specific; that is, the proteins of one species differ from those of another species. They are also organ -specific; for instance, within a single organism, muscle proteins differ from those of the brain and liver.

Chitosan-coated wires for biosensing

A method of forming a bioelectronic device including a protein on an electrically conductive substrate, by electro-depositing aminopolysaccharide chitosan on the substrate while applying a cathodic voltage to the substrate, to form an aminopolysaccharide chitosan film thereon, applying an anodic voltage to the substrate in the presence of NaCl to activate the aminopolysaccharide chitosan film so that it is reactive with protein. The method also optionally includes reacting the aminopolysaccharide film, after activation thereof, with the protein, so that the protein assembles on and is coupled to the substrate, thereby forming a bioelectronic device. The protein can include single or multiple protein species, and including biosensing proteins. Additional methods include biosensing of electrochemically active compounds either present in a sample or generated during a biological recognition event and devices useful in such methods. The resulting devices are useful as sensors in hand-held devices, textiles, garments and the like.
Owner:UNIV OF MARYLAND

Compositions and methods for proteomic investigations

Abstract of the Disclosure The present invention provides a variety of related proteomics analytical modalities that are open-ended, rapid, convenient and suitable for implementation in a high throughput parallel assay system. Specificity-determining compositions and methods are disclosed for use in proteomics. These compositions and methods provide a protein resolved from other protein species contained in a sample fluid, in its native, biologically functional conformation. The present invention provides a specificity-determining substrate that forms a complex with a protein molecule in a homogenous fashion. The specificity-determining substrate includes a specificity-determining ligand bound to a support, wherein optionally the substrate further includes a spacer bound between the ligand and the support. In addition a complex is provided that includes a specificity-determining substrate and a protein molecule. Furthermore, an array including a plurality of loci is provided, in which each locus includes a specificity-determining substrate of the invention. These substrates, complexes and arrays may be employed in a method of resolving a first protein from a fluid including one or more species of native, biologically active protein molecules, wherein the first protein retains its native structure and its biological activity; in a method of purifying one or more first proteins from a fluid including one or more species of native, biologically active protein molecules, wherein the purified first protein retains its native structure and its biological activity; in a method of characterizing one or more proteins in a fluid including one or more species of protein molecule; and in a method of identifying one or more proteins in a sample fluid wherein the concentration of the one or more proteins in the sample fluid differs from the concentration of the one or more proteins in a reference fluid.
Owner:ROY SWAPAN +2

Method for establishing quantitative reference range of healthy human urine proteome and database of healthy human urine proteome

The invention discloses a method for establishing a quantitative reference range of a healthy human urine proteome and a database of a healthy human urine proteome. The method comprises the steps thata statistical quantity of healthy human urine samples are made into urine protein samples, protein species and quantification of each protein are determined by mass spectrometric detection, library searching and quantification to form urine proteome data, different urine proteome data is collected into different urine proteome sub-data sets and total data sets, and the quantitative reference range of the healthy human urine proteome is obtained by the data calculation of the data sets. The established quantitative reference range of the human urine protein in the healthy human urine proteomedatabase can better exclude interference from physiological fluctuations and inter-individual differential protein in the discovery of urine protein biomarkers.
Owner:北京松果天目健康管理有限公司

Mass spectrometric immunoassay analysis of specific proteins and variants present in various biological fluids

InactiveUS7396687B2Adequate quantitative dynamic range and accuracy and linearityMicrobiological testing/measurementBiological testingProtein targetMass spectrometric immunoassay
Presented herein is the construction of pipettor tips (termed MSIA-Tips) containing porous solid supports that are constructed, covalently derivatized with affinity ligand, and used to extract specific proteins and their variants from various biological fluids by repeatedly flowing the fluids through the MSIA-Tips. A second protein species (a mass-shifted variant of the targeted protein doped into the samples at a constant concentration) is co-extracted with the endogenous protein and variants and is used as a quantitative internal reference standard (IRS). Nonspecifcally bound compounds are rinsed from the MSIA-Tip using a series of buffer and water rinses, after which the wild type protein, protein variants and the IRS are eluted from the MSIA-Tips directly onto a target in preparation for analysis such as MALDI-TOF. Mass spectrometry of the eluted sample then follows with the retained proteins identified via accurate molecular mass determination. Protein and variant levels are determined via a quantitative method in which the protein / variant signals are normalized to the signal of the IRS and the values compared to a working curve constructed from samples containing known concentrations of the protein or variants.
Owner:INTRINSIC BIOPROBES

Cast-to-shape electrokinetic trapping medium

A three-dimensional microporous polymer network material, or monolith, cast-to-shape in a microchannel. The polymer monolith, produced by a phase separation process, is capable of trapping and retaining charged protein species from a mixture of charged and uncharged species under the influence of an applied electric field. The retained charged protein species are released from the porous polymer monolith by a pressure driven flow in the substantial absence of the electric field. The pressure driven flow is independent of direction and thus neither means to reverse fluid flow nor a multi-directional flow field is required, a single flow through the porous polymer monolith can be employed, in contrast to prior art systems. The monolithic polymer material produced by the invention can function as a chromatographic medium. Moreover, by virtue of its ability to retain charged protein species and quantitatively release the retained species the porous polymer monolith can serve as a means for concentrating charged protein species from, for example, a dilute solution.
Owner:NAT TECH & ENG SOLUTIONS OF SANDIA LLC

Retinol formulations and methods for their use

A composition for the treatment of skin comprises a non-emulsified, aqueous suspension of retinol. The composition may further include at least one protein species, and some proteins used in the composition include collagen and elastin. The composition may also include hyaluronic acid. The composition may also include one or more of tocopheryl acetate, propylene glycol, and linseed extract. Also disclosed are methods for making the composition and use of the composition for the treatment of skin.
Owner:MILLSTEIN ELLIOTT

Soybean protein gel, preparation method and applications thereof

The invention discloses a soybean protein gel, a preparation method and applications thereof. The soybean protein gel is composed of the following raw materials in parts by weight: 0.5 to 1.5 parts of isolated soybean protein powder and 3.5 to 7 parts of ice water. The soybean protein gel is mainly prepared from isolated soybean protein powder and ice water; in the preparation method of the soybean protein gel, the isolated soybean protein powder is subjected to a pretreatment and is converted into protein gel before the isolated soybean protein powder is added into the product; thus the characteristics of the isolated soybean protein gel can be more fully exerted than directly adding the isolated soybean protein powder; the crispy degree and elasticity of pills are increased, the taste and the product quality are improved, the cost is reduced at the same time, plant protein is added to increase the protein content and enrich the protein species, so the product is benefit for human health.
Owner:SHANDONG HUIFA FOODS

Application of RNA Interference Targeting dhfr Gene, to Cell for Producing Secretory Protein

Biological materials are applied to a CHO cell or the like for enhancing production of a species of protein. The biological materials includes an expression vector and a silencing vector, the expression vector including a dhfr gene of a species of mammal and a gene encoding the species of protein, the silencing vector including a DNA fragment for inducing a RNA interference in the CHO cell to reduce expressions of both exogenous dhfr gene and endogenous dhfr gene after the biological material is applied to the CHO cell, and the CHO cell is thus not limited to dhfr gene deficient type. The DNA fragment consists of nucleotides characterizing a segment of a dhfr gene of the CHO cell and a segment of a dhfr gene of the species of mammal.
Owner:NATIONAL TSING HUA UNIVERSITY
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products